Chord Therapeutics

About:

Chord Therapeutics is a clinical stage biopharmaceutical company developing drugs for rare diseases.

Website: http://www.chordtherapeutics.com/

Twitter/X: chordtx

Top Investors: Omega Funds, Eclosion SA

Description:

Chord Therapeutics is a clinical-stage pharmaceutical company developing drugs for patients with rare, life-threatening, and severely disabling diseases. The company is advancing its lead drug candidate CRD1 under orphan drug designation for the treatment of neuromyelitis optica spectrum disorders (NMOSD) and myasthenia gravis (MG). The company was founded in 2014 and based in Geneva, Switzerland.